Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) EBT (2016 - 2025)

DarioHealth filings provide 13 years of EBT readings, the most recent being $8.8 million for Q4 2025.

  • On a quarterly basis, EBT fell 49.24% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$23.9 million, a 33.8% decrease, with the full-year FY2025 number at -$23.9 million, down 33.8% from a year prior.
  • EBT hit $8.8 million in Q4 2025 for DarioHealth, up from -$10.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $34.1 million in Q4 2021 to a low of -$22.4 million in Q3 2021.
  • Median EBT over the past 5 years was -$12.9 million (2023), compared with a mean of -$8.0 million.
  • The widest YoY moves for EBT: up 476.32% in 2021, down 330.98% in 2021.
  • DarioHealth's EBT stood at $34.1 million in 2021, then tumbled by 136.98% to -$12.6 million in 2022, then skyrocketed by 173.38% to $9.3 million in 2023, then surged by 86.46% to $17.3 million in 2024, then plummeted by 49.24% to $8.8 million in 2025.
  • The last three reported values for EBT were $8.8 million (Q4 2025), -$10.5 million (Q3 2025), and -$13.0 million (Q2 2025) per Business Quant data.